• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐万古霉素肠球菌(VRE)筛查结果对抗生素治疗合理性的影响。

Impact of a vancomycin-resistant (VRE) screening result on appropriateness of antibiotic therapy.

作者信息

Reynolds Jenna L, Trudeau Raelene E, Seville Maria Teresa, Chan Lynn

机构信息

Department of Pharmacy, Mayo Clinic Hospital, Phoenix, Arizona.

Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas, Texas.

出版信息

Antimicrob Steward Healthc Epidemiol. 2021 Nov 3;1(1):e41. doi: 10.1017/ash.2021.215. eCollection 2021.

DOI:10.1017/ash.2021.215
PMID:36168474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9495624/
Abstract

OBJECTIVE

Vancomycin-resistant (VRE) infections have been associated with increased mortality and poor outcomes. VRE screening has been used to identify colonized patients to prevent transmission; however, little is known about the utility of screening results to guide antibiotic therapy.

DESIGN AND SETTING

A retrospective review was performed at a tertiary-care center between June 1, 2015, and May 31, 2018.

PATIENTS

All patients who underwent VRE polymerase chain reaction assay (PCR) screening and had a bacterial culture from 7 days before to 90 days after the screening test were included. In total, 1,374 patients who had a VRE screening test met inclusion criteria.

METHODS

Sensitivity, specificity, and positive and negative predictive values of VRE screening for VRE infection were calculated. The appropriateness of the antibiotic therapy for each patient based on screening results was also assessed.

RESULTS

We detected no difference in the appropriateness of antibiotic therapy between patients with a positive screen and those with a negative screen (59.3% vs 61.0%; = .8657). The VRE PCR demonstrated 54% sensitivity, 89% specificity, a positive predictive value (PPV) of 13% and a negative predictive value (NPV) of 98%.

CONCLUSIONS

The high NPV and specificity indicate that patients with a negative VRE screening results may not require empiric antibiotic coverage for VRE. Although VRE screening may have utility to detect colonization in high-risk patients, a positive VRE screen is of limited value in determining the need for an antibiotic with VRE culture-directed coverage.

摘要

目的

耐万古霉素(VRE)感染与死亡率增加及不良预后相关。VRE筛查已用于识别定植患者以预防传播;然而,关于利用筛查结果指导抗生素治疗的效用知之甚少。

设计与背景

在一家三级医疗中心于2015年6月1日至2018年5月31日进行了一项回顾性研究。

患者

纳入所有接受VRE聚合酶链反应(PCR)筛查且在筛查试验前7天至试验后90天有细菌培养结果的患者。共有1374例进行VRE筛查试验的患者符合纳入标准。

方法

计算VRE筛查对VRE感染的敏感性、特异性、阳性预测值和阴性预测值。还根据筛查结果评估了每位患者抗生素治疗的适宜性。

结果

我们发现筛查结果为阳性的患者与筛查结果为阴性的患者在抗生素治疗适宜性方面没有差异(59.3%对61.0%;P = 0.8657)。VRE PCR显示敏感性为54%,特异性为89%,阳性预测值(PPV)为13%,阴性预测值(NPV)为98%。

结论

高阴性预测值和特异性表明VRE筛查结果为阴性的患者可能不需要针对VRE进行经验性抗生素覆盖。虽然VRE筛查可能有助于检测高危患者的定植情况,但VRE筛查结果为阳性在确定是否需要使用针对VRE培养结果指导的抗生素方面价值有限。

相似文献

1
Impact of a vancomycin-resistant (VRE) screening result on appropriateness of antibiotic therapy.耐万古霉素肠球菌(VRE)筛查结果对抗生素治疗合理性的影响。
Antimicrob Steward Healthc Epidemiol. 2021 Nov 3;1(1):e41. doi: 10.1017/ash.2021.215. eCollection 2021.
2
To swab or not to swab? A prospective analysis of 341 SICU VRE screens.是否进行拭子采样?341 例 SICU VRE 筛查的前瞻性分析。
J Trauma Acute Care Surg. 2014 May;76(5):1192-200. doi: 10.1097/TA.0000000000000203.
3
Predictive utility of swab screening for vancomycin-resistant Enterococcus in selection of empiric antibiotics for Enterococcus sterile-site infections: a retrospective cohort study.拭子筛查耐万古霉素肠球菌在选择用于肠球菌无菌部位感染经验性抗生素中的预测效用:一项回顾性队列研究
CMAJ Open. 2017 Aug 15;5(3):E632-E637. doi: 10.9778/cmajo.20170034.
4
A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization.抗生素暴露与万古霉素耐药肠球菌再定植的回顾性队列研究。
Infect Control Hosp Epidemiol. 2019 Apr;40(4):414-419. doi: 10.1017/ice.2019.15. Epub 2019 Feb 7.
5
Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia.使用 VRE 筛查试验预测肠球菌菌血症中的万古霉素耐药性。
Infect Control Hosp Epidemiol. 2020 Apr;41(4):425-429. doi: 10.1017/ice.2019.380. Epub 2020 Jan 24.
6
Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后早期定植患者经验性治疗万古霉素耐药肠球菌的影响。
Biol Blood Marrow Transplant. 2019 Mar;25(3):594-598. doi: 10.1016/j.bbmt.2018.11.008. Epub 2018 Nov 15.
7
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.耐万古霉素肠球菌定植与血流感染:急性髓系白血病患者异基因造血细胞移植后的患病率、危险因素及其对早期结局的影响
Transpl Infect Dis. 2016 Dec;18(6):913-920. doi: 10.1111/tid.12612. Epub 2016 Nov 11.
8
Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.既往已定植的造血干细胞移植患者中耐万古霉素肠球菌血症危险因素的评估。
Transpl Infect Dis. 2013 Oct;15(5):466-73. doi: 10.1111/tid.12120. Epub 2013 Aug 4.
9
The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients.机械通气患者中耐万古霉素肠球菌定植的发生率及相关临床变量。
Chest. 1999 Apr;115(4):1085-91. doi: 10.1378/chest.115.4.1085.
10
[Vancomycin-resistant enterococcus colonization in neonatal intensive care unit: prevention and eradication experience].新生儿重症监护病房耐万古霉素肠球菌定植:预防与根除经验
Mikrobiyol Bul. 2012 Oct;46(4):682-8.

引用本文的文献

1
Deciphering vancomycin resistance in : gene distribution, sequence typing, and global phylogenetic analysis.解析万古霉素耐药性:基因分布、序列分型及全球系统发育分析
Front Microbiol. 2025 Aug 15;16:1578903. doi: 10.3389/fmicb.2025.1578903. eCollection 2025.
2
Vancomycin-Resistant : Addressing Global and Clinical Challenges.耐万古霉素:应对全球和临床挑战。
Antibiotics (Basel). 2025 May 19;14(5):522. doi: 10.3390/antibiotics14050522.
3
Vancomycin-Resistant Enterococci: Screening Efficacy and the Risk of Bloodstream Infections in a Specialized Healthcare Setting.

本文引用的文献

1
Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia.使用 VRE 筛查试验预测肠球菌菌血症中的万古霉素耐药性。
Infect Control Hosp Epidemiol. 2020 Apr;41(4):425-429. doi: 10.1017/ice.2019.380. Epub 2020 Jan 24.
2
Predictive utility of swab screening for vancomycin-resistant Enterococcus in selection of empiric antibiotics for Enterococcus sterile-site infections: a retrospective cohort study.拭子筛查耐万古霉素肠球菌在选择用于肠球菌无菌部位感染经验性抗生素中的预测效用:一项回顾性队列研究
CMAJ Open. 2017 Aug 15;5(3):E632-E637. doi: 10.9778/cmajo.20170034.
3
Colonization With Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients With Malignancy: A Systematic Review and Meta-Analysis.
耐万古霉素肠球菌:在专业医疗环境中的筛查效果及血流感染风险
Antibiotics (Basel). 2025 Mar 16;14(3):304. doi: 10.3390/antibiotics14030304.
4
Vancomycin-Resistant Enterococci: Current Understandings of Resistance in Relation to Transmission and Preventive Strategies.耐万古霉素肠球菌:关于耐药性与传播及预防策略关系的当前认识
Pathogens. 2024 Nov 5;13(11):966. doi: 10.3390/pathogens13110966.
5
Infective Endocarditis after Transcatheter Aortic Valve Replacement: Challenges in the Diagnosis and Management.经导管主动脉瓣置换术后感染性心内膜炎:诊断与管理中的挑战
Pathogens. 2023 Feb 5;12(2):255. doi: 10.3390/pathogens12020255.
耐万古霉素肠球菌定植与恶性肿瘤患者血流感染风险:一项系统评价和荟萃分析
Open Forum Infect Dis. 2016 Dec 7;4(1):ofw246. doi: 10.1093/ofid/ofw246. eCollection 2017 Winter.
4
Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.时间至关重要:延迟抗生素治疗对医院获得性肠球菌血流感染患者预后的影响
Clin Infect Dis. 2016 May 15;62(10):1242-1250. doi: 10.1093/cid/ciw110. Epub 2016 Mar 3.
5
Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.重症监护病房中耐万古霉素肠球菌的定植:临床结局及住院归因成本
Am J Infect Control. 2014 Oct;42(10):1062-6. doi: 10.1016/j.ajic.2014.06.024.
6
Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.危重症患者肠球菌感染和耐万古霉素肠球菌定植的危险因素。
Infection. 2014 Dec;42(6):1013-22. doi: 10.1007/s15010-014-0678-1. Epub 2014 Aug 21.
7
To swab or not to swab? A prospective analysis of 341 SICU VRE screens.是否进行拭子采样?341 例 SICU VRE 筛查的前瞻性分析。
J Trauma Acute Care Surg. 2014 May;76(5):1192-200. doi: 10.1097/TA.0000000000000203.
8
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.与医疗保健相关感染相关的抗微生物药物耐药病原体:2009-2010 年向疾病预防控制中心国家医疗保健安全网络报告的数据摘要。
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14. doi: 10.1086/668770. Epub 2012 Nov 27.
9
Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission.入住重症监护病房的定植患者中万古霉素耐药肠球菌感染和死亡的危险因素。
Am J Infect Control. 2012 Dec;40(10):1018-9. doi: 10.1016/j.ajic.2012.01.009. Epub 2012 Apr 6.
10
Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006.2000 - 2006年美国耐万古霉素肠球菌感染的住院治疗长期趋势
Infect Control Hosp Epidemiol. 2009 Feb;30(2):184-6. doi: 10.1086/593956.